According to Spyre Therapeutics's latest financial reports the company's current earnings (TTM) are -ยฃ0.14 B. In 2023 the company made an earning of -ยฃ97.97 M a decrease over its 2022 earnings that were of -ยฃ64.6 M.The earnings displayed on this page is the company's Pretax Income.